featured
Pembrolizumab Plus Doxorubicin in Metastatic and Unresectable Soft Tissue Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Pembrolizumab in Combination With Doxorubicin in Metastatic and Unresectable Soft Tissue Sarcoma
Clin. Cancer Res 2021 Sep 02;[EPub Ahead of Print], MB Livingston, MH Jagosky, MM Robinson, WA Ahrens, JH Benbow, CJ Farhangfar, DM Foureau, DM Maxwell, EA Baldrige, X Begic, JT Symanowski, NM Steuerwald, CJ Anderson, JC Patt, JS Kneisl, ES KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.